Orthofix Medical Inc. Payments of Financing Costs
Orthofix Medical Inc. (OFIX) reported Payments of Financing Costs of $758.00 thousand for the 12-month period ending 2011-12-31, per its 10-K/A filed 2015-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2015-03-31
- Orthofix Medical Inc. payments of financing costs for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- Orthofix Medical Inc. payments of financing costs for the quarter ending 2011-09-30 was $0.00.
- Orthofix Medical Inc. payments of financing costs for the quarter ending 2010-12-31 was $280.00K.
- Orthofix Medical Inc. payments of financing costs for fiscal 2011 was $758.00K, a 82.23% decline from fiscal 2010.
- Orthofix Medical Inc. payments of financing costs for fiscal 2010 was $4.27M.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-03-31 | $0.00 derived: sum of 2 quarters · filed 2015-03-31 | $758.00K 10-K/A · filed 2015-03-31 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $758.00K 10-Q · filed 2012-11-02 | ||
| 2011-06-30 | $758.00K 10-Q · filed 2012-07-30 | |||
| 2010-12-31 | $280.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | $4.27M 10-K/A · filed 2014-03-24 | ||
| 2010-09-30 | $3.99M 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |